Marcus Anderson

Marc has a degree in economics and a MSc. in Finance. Marc worked for global investment firms in Europe and the United States as an analyst, fund manager, and consultant.

SunPower Corp (Nasdaq: SPWR) Announces Restructuring

Market Mover Alert on SunPower Corporation – Nasdaq ticker: SPWR

SunPower Corporation, majority owned by French energy giant Total SA, is up over 15% in heavy trading today. Investors seem to be positively responding to today’s news that Sunpower Corporation will be laying off 2,500 workers and closing a plant located in the Philippines as part of a company-wide restructuring effort. The company expects the move to move it into positive cashflow for 2017.

SunPower considers itself at the forefront of solar power innovation. The company operates in the residential, governmental, and utility sectors. Its headquarters are in San Jose, California and has offices in North America, Europe, Asia, and Africa.

The industry has been experiencing pricing pressures but the company expects some relief in the latter half of 2017. SunPower Corporation said that the average price for its products had decreased 25%. This is what most analysts believe will contribute to the company’s losses this quarter – its sixth quarterly loss in a row. SunPower said it expects to incur restructuring and other charges totaling about $200 million in the current quarter and restructuring charges of $225-$275 million through the end of 2017.

Shares of SPWR reacted positively to the news and had the effect of raising the share prices of other firms in the solar energy sector. SPWR has been a component stock of the Photovoltaik Global 30 Index since 2009

Always perform your own due diligence before making any decisions regarding the buy or sale of any stock. The below data is provided without any guarantee of its accuracy.

 

Ticker Symbol SPWR
Last Price a/o 2:45 EST  $           8.06
Average Volume 3 million
Market Cap $950 million
Sales $1.9 Billion
Shares Outstanding 135.9 million
Share Float 58.6 million
Shortable Yes
Optionable Yes
Inside Ownership 0.60%
Short Float 34.70%
Short Interest Ratio 6.7
Quarterly Return -31.80%
YTD Return -76.80%
Year Return -73.60%

 

Anthera Pharmaceuticals Inc (Nasdaq: ANTH) on the Move!

ANTH – Market Mover Alert!

Anthera Pharmaceuticals Inc., trading on the Nasdaq under ticker symbol ANTH, has seen a price a volume spike this morning. Anthera Pharmaceuticals recently elevated it President, Craig Thompson, to the Board level and to the position of CEO. Investors have responded to the news with volumes over ten time the normal trading volume in the first half-hour of trading; sending ANTH to an early morning gain of over 50%.

Anthera Pharmaceuticals Inc. is a California-based biotechnology company that focuses on innovative medicines. The company trades on the Nasdaq under the ticker symbol ANTH. They rely on two product candidates in development: Sollpura and Blisibimod. Sollpura is a biotechnology driven pancreatic replacement therapy for the potential treatment of exocrine pancreatic insufficiency in people suffering from cystic fibrosis. Blisibimod is a BAFF inhibitor for the potential treatment of systemic lupus erythematosus and IgA nephropathy. Company reports suggest that both drugs have made it through their respective Phase I and II clinical studies.

From Anthera Pharmaceuticals filing:

On December 2, 2016, upon recommendation of the Nominating and Corporate Governance Committee of the Board of Directors (the “Board”), Anthera Pharmaceuticals, Inc. (the “Company”) appointed Craig Thompson to serve on the Board as a Class I director and to serve as the Company’s Chief Executive Officer, effective December 6, 2016. Mr. Thompson will also continue to serve as the Company’s President.

Mr. Thompson was appointed to serve as the Company’s President and Chief Operating Officer effective January 7, 2016. Mr. Thompson, 50, has over 20 years of experience in pharmaceutical development and commercialization. Most recently he served as the Chief Operating Officer for Tetraphase Pharmaceuticals from February 2014 to December 2015, where he oversaw the development and implementation of the commercial strategy as well as the business development and commercial manufacturing. Prior to Tetraphase Pharmaceuticals, from January 2011 to December 2014, Mr. Thompson served as the Chief Commercial Officer for Trius Therapeutics resulting in the acquisition of Trius by Cubist Pharmaceuticals for over $700 million. Prior to Trius Therapeutics, Mr. Thompson held various positions of increasing responsibility with Pfizer from November 2003 to December 2010, with his last position as Vice President of Marketing, Specialty Care. Prior to Pfizer he held various positions of increasing responsibility at Merck and Co, Inc. from April 1993 to November 2003. Mr. Thompson holds a Bachelor’s degree in Commerce from McMaster University and a Master’s degree in Business Administration from the University of Notre Dame.

Always perform your own due diligence before making any decisions regarding the buy or sale of any stock. The below data on ANTH is provided without any guarantee of its accuracy.

Ticker Symbol ANTH
Last Price a/o 9:45 EST  $               2.39
Average Volume 618,000
Market Cap $56 million
Sales $2.1 million
Shares Outstanding 38 million
Share Float 36.8 million
Shortable Yes
Optionable Yes
Inside Ownership 12.46%
Short Float 15.90%
Short Interest Ratio 9.46
Quarterly Return -51%
YTD Return -68%
Year Return -68.00%

Republic First Bancorp (Nasdaq: FRBK) Announcement Sends Shares/Volumes Higher

Republic First Bancorp, trading under the Nasdaq ticker FRBK, released news this morning that has seen an intraday price increase of over 30% since yesterday’s close of trading. Volumes have also exploded to the upside with current daily trading volume in excess of twelve times the average daily volume.

Republic First Bancorp, Inc. is the holding company of a full-service, state-chartered commercial bank that does business under the name Republic Bank through approximately nineteen branches in southern New Jersey and the greater Philadelphia, PA area. Deposits are insured up to the applicable limits by the Federal Deposit Insurance Corporation (FDIC).

Republic First Bancorp, Inc, the holding company for Republic Bank, today announced that it completed the sale of $100 million of its common stock at a price of $5.35 per share and elected Vernon W. Hill, II as a Director and Chairman of Republic First Bancorp, Inc. Mr. Hill is considered as a forward thinking retail banker and has a history in the sector that includes being the Founder of Chairman of Commerce Bancorps and Metro Bank (UK).

The additional capital will be utilized to expand the growth opportunities of Republic Bank through the addition of new stores, primarily in southern New Jersey and the surrounding Philadelphia area.  The Bank has opened eight new locations over the last three years using its signature glass building. There are plans for additional stores during 2017 in Cherry Hill, Medford, Sicklerville and Blackwood, NJ and Fairless Hills and Bensalem, PA.

Investors appear to approve of the developments. FRBK closed under $6.00 on December 5, 2016 and rose to close to $8.00 in today’s morning trading. Average volumes have typically been under 60,000 shares but volumes are over ten times that level in intra-day trading today.

Always perform your own due diligence before making any decisions regarding the buy or sale of any stock. The below data is provided without any guarantee of its accuracy.

Ticker Symbol FRBK
Price $7.30
Average Volume 58k
Market Cap $230 million
Sales $52 million
Shares Outstanding 38.3 million
Share Float 31 million
Shortable Yes
Optionable Yes
Inside Ownership 30.00%
Short Float 3.86%
Short Interest Ratio 20.4
Quarterly Return 41%
YTD Return 39%
Year Return 33.00%

Oil Rig UDW (Nasdaq: ORIG) Set to Regain Former Price Levels?

The incoming Trump administration is believed to want to pursue an “energy independent America” policy. This will mean reversing many Obama-implemented regulations and asking Congress to pass laws that benefit the fossil fuel industry. One small cap Nasdaq stock that may benefit is Ocean Rig UDW LLC.

Ocean Rig UDW LLC, trading under Nasdaq ticker ORIG, is an international offshore drilling contractor providing oilfield services for offshore oil and gas exploration, development, and production drilling, and specializing in the ultra-deepwater and harsh-environment segment of the offshore drilling industry. 

Ocean Rig UDW LLC owns and operates 13 offshore ultra deepwater drilling units, comprising of 2 ultra deepwater semisubmersible drilling rigs and 11 ultra deepwater drillships, two of which are scheduled to be delivered to the Company during 2017 and one in 2018.

However, with the incoming Trump administration and the new OPEC deal designed to regulate output, it may be time to consider another look at this former high-flier. In 2014, ORIG routinely traded over $15 with and EPS of $1.97. ORIG now trades under $2. Sales increased from $700 million in 2011 to $1.82 billion in 2014. In 2015, Ocean Rig UDW LLC reported sales of just $1.75 billion with earnings per share of $0.57.

Zacks research has recently given it a #1 rating based on their proprietary analytics. This is important because no investment bank analysts have yet upgraded their recommendations for ORIG. Should the investment bank analysts follow suit, we may see a price target more than double its current trading price of below $2.00. Prior to OPEC flooding the market ORIG was given price targets around $30 by bank analysts.

Always perform your own due diligence before making any decisions regarding the buy or sale of any stock. The below data is provided without any guarantee of its accuracy.

Ticker Symbol ORIG
Price $1.50
Average Volume 2.5 million
Market Cap $146 million
Sales $1.9 Billion
Shares Outstanding 79 million
Share Float 73.5 million
Shortable Yes
Optionable Yes
Inside Ownership unkown
Short Float 15.30%
Short Interest Ratio 4.46
Quarterly Return 139%
YTD Return 14.11%
Year Return 7.50%

 

Neovasc Inc (Nasdaq: NVCN) Up Big in Early Trading

Shares of Neovasc Inc, trading on the Nasdaq under ticker NVCN, are up over 50% in early heavy trading. Neovasc Inc. is a specialty medical device company that develops, manufactures, and markets products for the rapidly growing cardiovascular marketplace.

This morning Neovasc Inc provided an update on its clinical experiences with its Tiara transcatheter mitral valve – a device that treats conditions that can lead to heart failure and death. Investors seem to welcome the news as NVCN volumes have exploded to over two million shares in early trading. NVCN ended yesterday with a closing price of around $1.42 but NVCN has traded over $2.00 today.

From NeoVasc Inc.’s press release:

To date, 22 patients have been treated with the Tiara™ valve at medical centers in Canada, the U.S. and Europe with more implantations scheduled for the coming weeks.  The technical success rate in these implantations was 19/22 or 86%.  In these technically successful implantations, paravalvular leak levels were reported as mild, trace or absent in 100% of these cases.  All cause 30-day mortality in the 19 patients who have reached 30 days post implant with Tiara™ is 15.7% (3/19).  The 3 remaining patients treated within the last 30 days are recovering well.  Of note, there has been no 30-day mortality reported in any of the last 8 patients treated over a month ago.  

Dr. Shmuel Banai, Neovasc Inc.’s Medical Director, presented the results at the ICI Meeting 2016 (ICI) in Tel Aviv, Israel.  ICI is the premier International Conference for Innovations in Cardiovascular Systems.

Information provided below is not guaranteed for its accuracy. As always perform your own due diligence before taking any action regarding any stocks. Biotechnology stocks are inherently risky.

Ticker Symbol NVCN
Price (EOD – ) $1.42
Average Volume 2.2 million
Market Cap $100 million
Sales $9.0 million
Shares Outstanding 67 million
Share Float 45 million
Shortable Yes
Optionable No
Inside Ownership 6.30%
Short Float 3.85%
Short Interest Ratio 0.81
Quarterly Return 141%
YTD Return -68.50%
Annual Return -66.00%

 


Fatal error: Call to undefined method WP_Image_Editor_Imagick::get_error_message() in /home3/c5d1p0f8/public_html/wp-content/plugins/core-extend/include/aq_resizer.php on line 157